0      0

2021 AABB Annual Meeting On-Demand

AM21-46: Oral Abstract Session -- Transfusion Medicine and Cellular Therapy Innovation


Oct 19, 2021 3:45pm ‐ Oct 19, 2021 4:45pm



Credits: None available.

Members: $20.00
Standard: $25.00

Description

Oral abstract session focused on Transfusion Medicine and Cellular Therapy Innovation.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • List demographic factors that impact anti-COVID-19 antibody levels in convalescent plasma donors.
  • Describe the qualities of antibody responses in blood donors who either had a prior COVID-19 infection or were vaccinated against COVID-19.
  • List proteomic markers that improve engraftment potential of fetal liver-derived hematopoietic stem cells.
  • Discuss steps that can be taken to improve survival of biotinylated red blood cells.

Moderator(s):

  • Thomas Gniadek, MD, PHD, University of Chicago (NorthShore) Pathology
  • Dr. Mary Berg, MD, Professor of Clinical Practice, Pathology Medical Director, Transfusion Services, University of Colorado

Speaker(s):

Disclosures

  • Kim Vanuytsel : Consultant: CSL Plasma
  • Amy Schmidt, MD, PhD : Consultant: CSL Plasma
  • Thomas Gniadek, MD, PHD : Consultant: Fresenius Kabi

Credits Available


AM21-46: Oral Abstract Session -- Transfusion Medicine and Cellular Therapy Innovation Evaluation

You must be logged in and own this session in order to post comments.